China Resources Double-Crane Pharmaceutical Co Ltd - Class A

SHSE:600062 (China)   Class A
Â¥ 23.19 (-0.81%) May 15
17.33
P/B:
2.09
Market Cap:
Â¥ 24.11B ($ 3.34B)
Enterprise V:
Â¥ 20.95B ($ 2.90B)
Volume:
5.39M
Avg Vol (2M):
11.03M
Volume:
5.39M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for China Resources Double-Crane Pharmaceutical Co Ltd ( ) from 1997 to May 15 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. China Resources Double-Crane Pharmaceutical stock (SHSE:600062) PE ratio as of May 15 2024 is 17.33. More Details

China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) PE Ratio (TTM) Chart

To

China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) PE Ratio (TTM) Historical Data

Total 1189
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
China Resources Double-Crane Pharmaceutical PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-05-16 17.5 2024-03-12 16.1
2024-05-15 17.5 2024-03-11 16.3
2024-05-14 17.6 2024-03-08 16.0
2024-05-13 17.8 2024-03-07 15.5
2024-05-10 17.6 2024-03-06 16.2
2024-05-09 17.4 2024-03-05 16.1
2024-05-08 17.1 2024-03-04 16.2
2024-05-07 17.3 2024-03-01 15.7
2024-05-06 17.2 2024-02-29 15.2
2024-05-03 16.3 2024-02-28 14.8
2024-05-02 16.3 2024-02-27 14.9
2024-04-30 16.3 2024-02-26 14.6
2024-04-29 15.9 2024-02-23 15.2
2024-04-26 15.8 2024-02-22 15.0
2024-04-25 16.0 2024-02-21 14.8
2024-04-24 15.8 2024-02-20 14.9
2024-04-23 15.7 2024-02-19 14.7
2024-04-22 15.9 2024-02-16 14.6
2024-04-19 15.7 2024-02-09 14.6
2024-04-18 15.4 2024-02-08 14.6
2024-04-17 15.3 2024-02-07 14.7
2024-04-16 15.4 2024-02-06 14.2
2024-04-15 15.3 2024-02-05 13.2
2024-04-12 14.6 2024-02-02 12.9
2024-04-11 14.8 2024-02-01 13.3
2024-04-10 15.2 2024-01-31 13.4
2024-04-09 15.4 2024-01-30 14.0
2024-04-08 15.3 2024-01-29 14.4
2024-04-05 15.5 2024-01-26 14.3
2024-04-03 15.5 2024-01-25 14.1
2024-04-02 15.3 2024-01-24 13.1
2024-04-01 15.5 2024-01-23 13.0
2024-03-29 15.4 2024-01-22 12.6
2024-03-28 15.1 2024-01-19 13.3
2024-03-27 15.6 2024-01-18 13.5
2024-03-26 15.5 2024-01-17 13.6
2024-03-25 15.7 2024-01-16 13.8
2024-03-22 15.8 2024-01-15 13.8
2024-03-21 16.3 2024-01-12 13.5
2024-03-20 16.4 2024-01-11 13.7
2024-03-19 16.2 2024-01-10 13.8
2024-03-18 16.5 2024-01-09 14.0
2024-03-15 15.9 2024-01-08 13.9
2024-03-14 15.9 2024-01-05 14.1
2024-03-13 15.8 2024-01-04 14.5

China Resources Double-Crane Pharmaceutical Co Ltd (SHSE:600062) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is engaged in developing, manufacturing and marketing a variety of medical products. The company's products cover different fields such as infusion field, cardiovascular and cerebrovascular fields, pediatrics, endocrine field and other areas.